UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December, 2023
Commission File Number: 001-15092
TURKCELL ILETISIM HIZMETLERI A.S.
(Translation of registrant’s name into English)
Aydınevler Mahallesi İnönü Caddesi No:20
Küçükyalı Ofispark
34854 Maltepe
Istanbul, Turkey
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Enclosure: A press release dated December 19, 2023, announcing the capital increase in Lifecell Ventures.
Istanbul, December 19, 2023
Announcement Regarding the Capital Increase in Lifecell Ventures
The capital of our Company's subsidiary Lifecell Ventures Coöperatief U.A. ("Lifecell Ventures") is increased by EUR 3,762,617 to EUR 1,780,624,890 from EUR 1,776,862,273. The entire capital commitment has been paid by our Company.
For more information:
Turkcell Investor Relations
investor.relations@turkcell.com.tr
Tel: + 90 212 313 1888
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Turkcell Iletisim Hizmetleri A.S. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TURKCELL ILETISIM HIZMETLERI A.S. | ||||
| Date: December 19, 2023 | By: | /s/ Beren Erdem Hamaratgil | ||
Name: Beren Erdem Hamaratgil Title: Investor Relations Associate Director | ||||
| TURKCELL ILETISIM HIZMETLERI A.S. | ||||
| Date: December 19, 2023 | By: | /s/ Kamil Kalyon | ||
| Name: Kamil Kalyon Title: Chief Financial Officer | ||||